Annexon Inc

General ticker "ANNX" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $705.6M

Annexon Inc follows the US Stock Market performance with the rate: 35.5%.

Estimated limits based on current volatility of 3.9%: low 4.99$, high 5.39$

Factors to consider:

  • Price in estimated range
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [2.29$, 6.26$]
  • 2024-12-30 to 2025-12-30 estimated range: [2.20$, 6.01$]

Financial Metrics affecting the ANNX estimates:

  • Negative: Non-GAAP EPS, $ of -1.78 <= 0.10
  • Negative: Operating profit margin, % of -100 <= 1.03
  • Negative: negative Net income
  • Negative: Operating cash flow per share per price, % of -36.34 <= 2.35
  • Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
  • Positive: Inventory ratio change, % of 0 <= 0

Similar symbols

Short-term ANNX quotes

Long-term ANNX plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $130.71MM $145.60MM $143.72MM
Operating Income $-130.71MM $-145.60MM $-143.72MM
Non-Operating Income $0.39MM $3.65MM $9.49MM
R&D Expense $100.07MM $112.50MM $113.76MM
Income(Loss) $-130.32MM $-141.95MM $-134.24MM
Profit(Loss) $-130.32MM $-141.95MM $-134.24MM
Stockholders Equity $231.91MM $231.19MM $250.56MM
Assets $287.04MM $285.10MM $297.67MM
Operating Cash Flow $-106.11MM $-116.31MM $-121.14MM
Capital expenditure $1.65MM $6.53MM $0.19MM
Investing Cash Flow $-88.24MM $58.44MM $70.70MM
Financing Cash Flow $1.79MM $122.91MM $135.52MM
Earnings Per Share* $-3.34 $-2.53 $-1.77

* EPS are Split Adjusted, recent splits may be reflected with a delay.